Journal
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
Volume 22, Issue 4, Pages 249-273Publisher
WILEY
DOI: 10.1002/jhbp.233
Keywords
Ampullary carcinoma; Bile duct carcinoma; Biliary tract cancer; Gallbladder carcinoma
Categories
Funding
- Isayama H, Boston Scientific Japan, Tokyo, Japan
- Taiho Pharma, Tokyo, Japan
- Yakult Pharmaceutical Industry Co., Ltd., Tokyo, Japan
- Piolax Inc., Yokohama, Japan
- Unno M, Takeda Pharmaceutical Co., Ltd., Osaka, Japan
- Chugai pharmaceutical Co., Ltd., Tokyo, Japan
- Janssen Pharmaceutical K., K., Tokyo, Japan
- Ousaka T, Taiho Pharma, Tokyo, Japan
- Onco Therapy Science, Inc., Kawasaki, Japan
- Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan
- Bayer Yakuhin, Osaka, Japan
- Eisai Co., Ltd., Tokyo, Japan
- Bristol-Myers Squibb, Tokyo, Japan
- Eli Lily Japan
- Kobe, Japan
- Novartis Pharma, Tokyo, Japan
- Takeda Pharmaceutical Co., Ltd., Osaka, Japan
- Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan
- Boehringer Inglheim Japan, Inc., Tokyo, Japan
- Kowa Pharmaceutical Co., Ltd., Tokyo, Japan
- Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan
- Merck Serono Japan, Tokyo, Japan
- Ono pharmaceutical Co., Ltd., Osaka, Japan
- AstraZeneca K. K., Osaka, Japan
- Furuse J, Taiho Pharma, Tokyo, Japan
- Pfizer Japan Inc., Tokyo, Japan
- Glaxo SmithKline K. K., Tokyo, Japan
- Zeria Pharmaceutical Co., Ltd., Tokyo, Japan
- Miyazaki M, Eli Lily Japan
- Sanofi K. K., Tokyo, Japan
- Murakami K, FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan
Ask authors/readers for more resources
Background The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract and ampullary carcinomas in 2008. Novel treatment modalities and handling of clinical issues have been proposed after the publication. New approaches for editing clinical guidelines, such as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, also have been introduced for better and clearer grading of recommendations. Methods Clinical questions (CQs) were proposed in seven topics. Recommendation, grade of recommendation and statement for each CQ were discussed and finalized by evidence-based approach. Recommendation was graded to grade 1 (strong) and 2 (weak) according to the concept of GRADE system. Results The 29 CQs covered seven topics: (1) prophylactic treatment, (2) diagnosis, (3) biliary drainage, (4) surgical treatment, (5) chemotherapy, (6) radiation therapy, and (7) pathology. In 27 CQs, 19 recommendations were rated strong and 11 recommendations weak. Each CQ included the statement of how the recommendation was graded. Conclusions This guideline provides recommendation for important clinical aspects based on evidence. Future collaboration with cancer registry will be a key for assessment of the guidelines and establishment of new evidence. Free full-text articles and amobile application of this guideline are available via http://www.jshbps.jp/en/guideline/biliary-tract2.html.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available